688825.SH · A-shares

688825.SH CXMT: LPDDR6 MP + H1'26 beat

CXMT (688825.SH) H1'26 revenue ¥150.310B (+873.64%), parent NI ¥77.605B, OCF ¥131.156B, main GM ~84.8%—well above prior guide. On 2026-08-29 announced **LPDDR6 mass production** (12,800 Mbps / up to 16GB); Xiaomi 18 Fold first attach, Xuanjie O3 first SoC. A-share ~¥58.6 / mkt ~¥3.98T. Debate: cycle delivery vs valuation stretch. Cf. Micron MU.

Published Updated Open interactive reader

Download MarkdownExport PDF

Cite a section with a deep link, e.g. /en/r/cxmt-688825-research#thesis

Market snapshot

A-share (~8/28)
CNY 58.6
Market cap (approx)
CNY 3980.0B
H1'26 revenue
CNY 150.3B
H1'26 parent NI
CNY 77.6B
As of 2026-09-25

As-of 2026-09-25 (weekly refresh; equities aligned to §A. Missing series are N/A/null. Not investment advice.)

Thesis

CXMT (ChangXin Memory listco, 688825.SH) is China's leading integrated DRAM designer-manufacturer; STAR IPO on 2026-07-27. 2025 revenue ¥61.799B, consolidated NI ¥7.144B, parent NI ¥1.875B (first annual profit).

H1'26 delivered: revenue ¥150.310B (+873.64%), parent NI ¥77.605B (vs −¥2.332B prior-year; non-GAAP parent NI ¥78.793B), OCF ¥131.156B; main-business gross margin ~84.8%. Results beat the prior H1 guide (rev ¥110–120B / parent NI ¥50–57B).

Product milestone: on 2026-08-29 CXMT announced LPDDR6 mass production (H1 report still said sampling / accelerating ramp)—peak 12,800 Mbps, up to 16GB per chip; Xiaomi 18 Fold first attach, Xuanjie O3 first supporting SoC. Peer: Micron MU.

A-share ~¥58.6 / mkt ~¥3.98T (2026-08-28)—cycle delivery meets stretched valuation.

Business

Model: DRAM IDM selling wafers/chips/modules into consumer, server, PC, and auto. Earnings tied to DRAM prices and utilization. Company states it is China's #1 and global #4 DRAM vendor by volume and sales.

Flagships: LPDDR line (2025 LPDDR ~¥40.7B, ~66% of main revenue)—now LPDDR6 in volume; DDR5 for server/PC; automotive LPDDR4X/LPDDR5X in production.

Competitiveness: Scarce China DRAM IDM scale; 2025 turnaround + H1'26 beat; LPDDR6 first commercial attach strengthens flagship narrative.

Strategy (12–24m): Gen-4 process in volume, Gen-5 customer quals; broaden LPDDR6 beyond first phone; HBM/high-bandwidth still the gap vs Big 3. Near-term still DRAM-price led.

Value chain

Position: midstream memory IDM — upstream tools/materials; downstream OEMs/module houses (Alibaba Cloud, ByteDance, Tencent, Lenovo, Xiaomi, Transsion, Honor, OPPO, vivo, etc.).

Supply-chain risks: Advanced tool/material export controls; DRAM price and customer concentration; early LPDDR6 attach concentrated in few flagship platforms.

Price & valuation

Share price · ~3y

Interactive chart available in the reader.

Quarterly close reconstruction from public quotes; post-IPO volatile; ~¥58.6 on 2026-08-28. Earlier points pending named-source verification. · As of 2026-09-25

Valuation multiples · recent quarters

Interactive chart available in the reader.

Pre-IPO: no public quotes (PE/PB null). 2026Q2: ~¥3.98T mkt / H1 parent NI annualized (¥77.605B×2) ≈2.6x PE; PB ≈29.5x on parent equity. No dividend. ann_return = gain vs IPO issue price (not TTM). 2025Q4/2026Q1 multiples lack independent checkpoints → null. · As of 2026-09-25

Valuation snapshot

Valuation snapshot
MetricValueNote
P/E (H1 annualized)~2.6x¥3.98T / (¥77.605B×2); optically low at cycle peak
P/B~29.5xvs parent equity ¥134.722B @ 2026-06-30
Earnings yield~39%1 / ~2.6x; not durable if ASP fades
Spot read~¥58.6 / ¥3.98T2026-08-28 close context
As of 2026-09-25

~1 month post-IPO, price up ~6× from issue; 2026-08-28 close ~¥58.6 / ~¥3.98T mkt. H1 annualized PE ~2.6x but PB ~29.5x—optically cheap PE is typical at a cyclical profit peak. Real debate: DRAM price durability and whether LPDDR6/share gains cushion a fade.

Financial health

Financial health
ItemValueNote
Health summaryStrong cash / net cashH1 OCF >> NI; cash covers interest-bearing debt
H1'26 OCF¥131.156B+2985.64% YoY; collections from DRAM sales
Cash & cash equiv.~¥133.5BMonetary funds ¥143.4B @ 2026-06-30
Interest-bearing debt~¥120.8BST loans ¥11.1B + LT loans ¥109.7B
AuditH1 unauditedPer H1 report; annual audit pending
As of 2026-09-25

Financial trend (~24 months)

~8Q with YoY/QoQ. Notes: 2026Q1/Q2 anchored to disclosed figures and H1 residuals (Q1 rev ¥50.8B / parent NI ¥24.762B; Q2 rev ~¥99.5B / parent NI ~¥52.8B); earlier quarters omitted/null without disclosure. H1 GM ~84.8%.

Revenue · last 8 quarters

Interactive chart available in the reader.

Disclosed anchors only: Q1'26 rev ¥50.8B and +719.13% YoY imply Q1'25; H1'25 ¥15.438B implies Q2'25; H1'26 ¥150.310B residual → Q2'26. Missing QoQ/YoY = null; no undisclosed fill-in. · As of 2026-09-25

Gross margin · last 8 quarters

Interactive chart available in the reader.

H1'26 main GM 84.84% (interim report); no quarterly GM split — Q1/Q2'26 use H1 print; earlier quarters null. · As of 2026-09-25

Parent NI · last 8Q

Interactive chart available in the reader.

Q1'26 parent NI ¥24.762B + YoY (company); H1'26 ¥77.605B residual → Q2'26; H1'25 −¥2.332B with Q1 YoY implies Q1/Q2'25. Q2'26 YoY null vs prior-year loss. · As of 2026-09-25

Operations

Key financials & product

Key financials & product
ItemValueYoYNote
H1'26 revenue¥150.310B+873.64%Beat ¥110–120B guide
H1'26 parent NI¥77.605Bturnaroundvs −¥2.332B; non-GAAP ¥78.793B
H1'26 OCF¥131.156B+2985.64%Cash conversion strong
H1'26 main GM~84.8%—COGS only +71% YoY
LPDDR6MP (2026-08-29)—Xiaomi 18 Fold first; 12800Mbps / 16GB
As of 2026-09-25

H1 COGS only +71% YoY while revenue ~9× → margin/cash explosion. R&D spend ~¥6.859B (+87%). Company expects global DRAM tight supply to persist in H2'26.

Competition

Peers: Samsung, SK hynix, Micron. CXMT claims global #4; LPDDR6 commercial first-mover vs Big 3 still mostly on LPDDR5/5X with 2H'26 MP plans—watch specs/process (e.g. 1c) vs attach wins.

Strengths: Domestic capacity; cyclical leverage; LPDDR6 + auto product breadth.

Weaknesses: HBM/leading-edge gap; rich valuation; large NCI (H1 minority interest ~¥30B) widens parent vs consol. NI.

Market share trend · last 8Q

Interactive chart available in the reader.

Company: China #1 / global #4; series illustrative from public sources. · As of 2026-09-25

Peer market share comparison (latest est.)

Interactive chart available in the reader.

Industry + company disclosures (illustrative); Big 3 still dominate globally. · As of 2026-09-25

Peer comparison

Peer comparison
CompanyShare / positionMarginStrengthWeakness
长鑫科技 688825中国第一 / 全球第四(公司口径)H1'26 主营 ~84.8%LPDDR6 商用量产首发;周期弹性HBM/最先进制程落后;估值高
美光 MU全球 DRAM 三巨头周期领先先进制程与客户地缘与对华限制
SK 海力士全球三巨头HBM 领先HBM/先进DRAM资本开支周期
三星电子全球三巨头规模最大产能与垂直整合存储价格周期
As of 2026-09-25

Management

Per prospectus/H1 filings; key 24m event is Jul 2026 STAR IPO. H1: no applicable director/executive/core-tech changes.

Stability call: Transition — post-IPO governance/disclosure; watch lockups and appointments.

Key management (24m)

Key management (24m)
RoleNameSince24m change
董事长见招股书/年报上市前后披露科创板 IPO(2026-07);核心团队以招股披露为准
总经理/CEO见招股书披露任职上市窗口期,关注后续高管公告
财务负责人见招股书披露任职期间以招股及上市后公告为准
技术负责人见招股书披露任职制程路线与产能相关
As of 2026-09-25

Outlook

Near term: DRAM spot/contract prices, utilization, LPDDR6 ramp and more OEM/SoC wins, Gen-5 quals, key-customer share. FY26 earnings highly price-dependent; LPDDR6 is a generation proof-point, secondary to ASP near term.

Scenarios

Scenario Conditions Implication
Bull Firm DRAM; LPDDR6 scales; share gains Rich multiple partly earned
Base High prices chop; tough H1 comps; LPDDR6 flagship-limited Volatile hold / trade
Bear Sharp memory fade; lockup/sentiment unwind; LPDDR6 miss NI + multiple crush

Risks

Tracking

Check next quarter/annual:

  1. DRAM ASP / contract prices stay tight (falsify: two-quarter fade)
  2. LPDDR6 revenue/share and more SoC/OEM wins beyond Xiaomi 18 Fold
  3. Gross margin resilience if ASP softens (vs H1 ~84.8%)
  4. OCF vs CapEx for capacity/process upgrades
  5. Gen-5 process quals and auto LPDDR ramp

References

Key sources:

Not investment advice; defer to latest filings. “Mass production” per company Weibo/filings; commercial scale per terminal attach.

Disclaimer: For research information only. Not investment advice or a recommendation to buy or sell.

Comments

Sign in to comment

Loading…